Cellectis and BASF Plant Science broaden their collaboration to use engineered meganucleases in crops
Paris, March 4, 2010 – Cellectis (Alternext: ALCLS), the French Genome engineering specialist, has announced that BASF Plant Science has just broadened its license to use Cellectis’ meganuclease technology. BASF Plant Science is the plant Biotechnology business of one of the world’s leading chemical company, BASF, and specializes in the research, development and commercialization of transgenic crops.
This agreement extends the license signed by Cellectis and BASF Plant Sciences in January 2006. Under a non-exclusive license, BASF Plant Science will use Meganucleases engineered by Cellectis to make targeted modifications of plant genomes.
Financial terms and conditions of the agreement were not disclosed.
“The broadening of an agreement with a high-profile company that has been using our tools and technology for three years is very good news,” said André Choulika, Cellectis CEO. “It confirms that major players in the global agricultural Biotechnology field have a high level of confidence that Cellectis’ meganuclease technology has an unparalleled ability to develop the next generation of high added value crops.”
